Bristol-Myers Squibb Co (BMY)
44.03
-0.08
(-0.18%)
USD |
NYSE |
May 17, 16:00
44.00
-0.03
(-0.07%)
Pre-Market: 20:00
Bristol-Myers Squibb SG&A Expense (Annual): 7.772B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.772B |
| December 31, 2022 | 7.814B |
| December 31, 2021 | 7.69B |
| December 31, 2020 | 7.661B |
| December 31, 2019 | 4.871B |
| December 31, 2018 | 4.551B |
| December 31, 2017 | 4.751B |
| December 31, 2016 | 4.979B |
| December 31, 2015 | 5.001B |
| December 31, 2014 | 5.699B |
| December 31, 2013 | 5.104B |
| December 31, 2012 | 5.175B |
| December 31, 2011 | 5.17B |
| December 31, 2010 | 4.691B |
| December 31, 2009 | 5.214B |
| December 31, 2008 | 5.354B |
| December 31, 2007 | 6.32B |
| December 31, 2006 | 6.14B |
| December 31, 2005 | 6.453B |
| Date | Value |
|---|---|
| December 31, 2004 | 6.427B |
| December 31, 2003 | 6.035B |
| December 31, 2002 | 5.267B |
| December 31, 2001 | 5.193B |
| December 31, 2000 | 5.532B |
| December 31, 1999 | 5.338B |
| December 31, 1998 | 5.203B |
| December 31, 1997 | 6.414B |
| December 31, 1996 | 5.871B |
| December 31, 1995 | 5.316B |
| December 31, 1994 | 4.533B |
| December 31, 1993 | 5.981B |
| December 31, 1992 | 6.339B |
| December 31, 1991 | 5.463B |
| December 31, 1990 | 5.037B |
| December 31, 1989 | 5.45B |
| December 31, 1988 | 4.304B |
| December 31, 1987 | 3.789B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
4.871B
Minimum
2019
7.814B
Maximum
2022
7.162B
Average
7.69B
Median
2021
SG&A Expense (Annual) Benchmarks
| Amgen Inc | 6.179B |
| Gilead Sciences Inc | 6.09B |
| Johnson & Johnson | 20.11B |
| Eli Lilly and Co | 6.941B |
| 2seventy bio Inc | 69.41M |